{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Portage Biotech Inc."},"Symbol":{"label":"Symbol","value":"PRTG"},"Address":{"label":"Address","value":"CRAIGMUIR CHAMBERS,TORTOLA, ROAD TOWN, VG1110, Virgin Islands (British)"},"Phone":{"label":"Phone","value":"+1 416 929-1806"},"Industry":{"label":"Industry","value":"Oil & Gas Production"},"Sector":{"label":"Sector","value":"Energy"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.portagebiotech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ian B. Walters","title":"Chief Executive Officer"},{"name":"Robert Alan Kramer","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}